Science-Driven Clinical Research for Life-Changing Therapeutics Across the Metabolic Continuum
We are the leading clinical research organization focused on metabolic continuum diseases. We collaborate globally with pharmaceutical, biotech, and medical device partners to advance clinical research for new therapeutics and improve health outcomes for patients. This is based on a deep understanding of the pathophysiology and interconnectedness of disorders across the continuum of metabolic diseases.
Recognizing metabolic diseases as a continuum represents a shift from traditional silos of disease-specific research. We enable a clearer understanding of complex concomitant disorders that share common risk factors, including obesity, diabetes, steatotic liver disease, cardiovascular disease, chronic kidney disease, and neurodegenerative diseases.
